B3gnt5 - UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 Gene
Also Known as beta3GnT5
Species: Mus musculus
Summary
Predicted to enable beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity. Predicted to be involved in brain development. Predicted to act upstream of or within sphingolipid biosynthetic process. Predicted to be located in Golgi apparatus and membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi membrane. Is expressed in several structures, including alimentary system; eye; genitourinary system; hemolymphoid system gland; and nervous system. Orthologous to human B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5). [provided by Alliance of Genome Resources, Apr 2022]
B3gnt5 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001159407.1 | NP_001152879.1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase |
| NM_001159408.1 | NP_001152880.1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase |
| NM_054052.3 | NP_473393.2 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01312 | B3GNT5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21099 | B3gnt5 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27617 | B3gnt5 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service